ClinicalTrials.Veeva

Menu

HFNC vs NPPV After Early Extubation for Patients With COPD

C

Chinese PLA General Hospital (301 Hospital)

Status

Unknown

Conditions

Hypercapnic Respiratory Failure
COPD

Treatments

Device: HFNC
Device: NPPV

Study type

Interventional

Funder types

Other

Identifiers

NCT04156139
2018ZX09201013

Details and patient eligibility

About

High-flow nasal cannula oxygen therapy(HFNC) has proved no significant difference compared with noninvasive positive pressure ventilation (NPPV) in preventing postextubation respiratory failure and reintubation in patients with acute hypoxemic respiratory failure.However, the efficacy of early postextubation sequential HFNC in COPD patients with hypercapnic respiratory failure is inconclusive.

Full description

The investigators conducted this prospective randomized controlled trial to explore the efficacy, safety of HFNC versus NPPV after early extubation in COPD patients with hypercapnic respiratory failure.The investigators hypothesized that the efficacy of HFNC after early extubation is non-inferior to that of NPPV.

Enrollment

502 estimated patients

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. COPD patients with bronchopulmonary infection 2. Patients with hypercapnia respiratory failure treated with invasive mechanical 3.14 days ≥ invasive mechanical ventilation ≥ 48 hours; 4.Reached the pulmonary infection control (PIC) window; 5.Have self-care ability with oxygen supply during stable phrase

Exclusion criteria

  • Severe organ dysfunction;Myopathy or myasthenia gravis;Upper airway obstruction;A large amount of secretions and inability to drain;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

502 participants in 2 patient groups

Control group
Active Comparator group
Description:
NPPV treatment for patients will be performed for patients immediately after extubation in control group.
Treatment:
Device: HFNC
Device: NPPV
intervention group
Experimental group
Description:
HFNC treatment will be performed for patients immediately after extubation in the intervention group.
Treatment:
Device: HFNC
Device: NPPV

Trial contacts and locations

1

Loading...

Central trial contact

Han Xiaobo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems